Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bonanni

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy womenA Decensi, C Robertson, B Ballardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2015
Long-term effects of inhaled budesonide on screening-detected lung nodulesG Veronesi, M Lazzeroni, E Szabo, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Breast (Edinburgh, Scotland)|June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51DR Graffeo, H Q Rana, F Conforti, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy womenA Decensi, C Robertson, B Ballardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2015
Long-term effects of inhaled budesonide on screening-detected lung nodulesG Veronesi, M Lazzeroni, E Szabo, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Breast (Edinburgh, Scotland)|June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51DR Graffeo, H Q Rana, F Conforti, et al.
Pageof 5